Financhill
Back

AngioDynamics Quote, Financials, Valuation and Earnings

AngioDynamics Price Quote

$6.08
+0.29 (+5.01%)
(Updated: May 2, 2024 at 5:50 PM ET)

AngioDynamics Key Stats

Sell
35
AngioDynamics (ANGO) is a Sell

Day range:
$5.71 - $5.98
52-week range:
$5.26 - $11.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.72
P/B ratio:
1.06%

Volume:
333.4K
Avg. volume:
627.2K
1-year change:
-32.67%
Market cap:
$231.9M
Revenue:
$338.8M
EPS:
$-4.78

How Much Does AngioDynamics Make?

Is AngioDynamics Growing As A Company?

  • What Is AngioDynamics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.07%
  • What Is AngioDynamics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

AngioDynamics Stock Price Performance

  • Did AngioDynamics Stock Go Up Last Month?
    AngioDynamics share price went down by -0.69% last month
  • Did ANGO's Share Price Rise Over The Last Year?
    ANGO share price fell by -32.67% over the past 1 year

What Is AngioDynamics 52-Week High & Low?

AngioDynamics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AngioDynamics?

  • How Much Debt Does AngioDynamics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does AngioDynamics Have?
    Cash and short term investments quarterly total is $78.5M
  • What Is AngioDynamics’s Book Value Per Share?
    Book value per share is 5.41

Is AngioDynamics Cash Flow Positive?

  • What Is ANGO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.2M
  • What Is AngioDynamics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$59.2M
  • What Is AngioDynamics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $124.5M

AngioDynamics Return On Invested Capital

  • Is Management Doing A Good Job?
    ANGO return on invested capital is -49.26%
  • What Is AngioDynamics Return On Assets?
    ROA measures how assets are converting to revenues and is -40.18%
  • What Is ANGO Return On Equity?
    ROE is a measure of profitability and is -52.74%

AngioDynamics Earnings Date & Stock Price

AngioDynamics Competitors

  • Who Are AngioDynamics's Competitors?
    Below is a list of companies who compete with AngioDynamics or are related in some way:
    • Becton Dickinson & Co (BDX)
    • Perspective Therapeutics Inc (CATX)
    • Integer Holdings Corp (ITGR)
    • Outset Medical Inc (OM)
    • Xtant Medical Holdings Inc (XTNT)

AngioDynamics Dividend Yield

Data Unavailable

AngioDynamics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.23%
Revenue: -6.85% -11.1%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 13.50
Upside from Last Price: 133.16%

Major Shareholders

  • How many ANGO shares are owned by institutional investors?
    46.1M ANGO shares are owned by institutional investors
  • How many ANGO shares are owned by insiders?
    4.9M ANGO shares are owned by insiders